L10, 11-DPS3

General Information


DRACP ID  DRACP00829

Peptide Name   L10, 11-DPS3

Sequence  ALWKDILKNLLKAALNEINQIVQ

Sequence Length  23

UniProt ID  Not available

PubChem CID  Not available

Origin  skin secretion of Phyllomedusa sauvagii

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H157 Lung squamous cell carcinoma Carcinoma IC50=0.12 μM MTT assay 24h 1
PC-3 Prostate carcinoma Carcinoma IC50=1.85 μM MTT assay 24h 1

Hemolytic Activity  Horse blood cells: HC50=3.44 μM

Normal (non-cancerous) Cytotoxicity  HMEC-1: IC50=8.76 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00829

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C122H206N32O33

Absent amino acids  CFGHMPRSTY

Common amino acids  L

Mass  304181

Pl  9.44

Basic residues  3

Acidic residues  2

Hydrophobic residues  13

Net charge  1

Boman Index  -1202

Hydrophobicity  21.74

Aliphatic Index  161.3

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  250

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30087268

Title  Biological Activities of Cationicity-Enhanced and Hydrophobicity-Optimized Analogues of an Antimicrobial Peptide, Dermaseptin-PS3, from the Skin Secretion of Phyllomedusa sauvagii

Doi 10.3390/toxins10080320

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.